960 related articles for article (PubMed ID: 19185651)
1. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
2. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
Marijon E; Trinquart L; Otmani A; Leclercq C; Fauchier L; Chevalier P; Klug D; Defaye P; Lellouche N; Mansourati J; Deharo JC; Sadoul N; Anselme F; Maury P; Davy JM; Extramiana F; Hidden-Lucet F; Probst V; Bordachar P; Mansour H; Chauvin M; Jouven X; Lavergne T; Chatellier G; Le Heuzey JY;
Am Heart J; 2010 Apr; 159(4):659-664.e1. PubMed ID: 20362726
[TBL] [Abstract][Full Text] [Related]
3. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
4. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
6. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
[TBL] [Abstract][Full Text] [Related]
7. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
8. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
12. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
[TBL] [Abstract][Full Text] [Related]
13. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
14. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Olshansky B; Wood F; Hellkamp AS; Poole JE; Anderson J; Johnson GW; Boineau R; Domanski MJ; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2007 Jun; 153(6):1089-94. PubMed ID: 17540216
[TBL] [Abstract][Full Text] [Related]
15. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.
Schernthaner C; Pichler M; Strohmer B
Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140
[TBL] [Abstract][Full Text] [Related]
16. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period.
Duray GZ; Schmitt J; Richter S; Israel CW; Hohnloser SH
Europace; 2009 Nov; 11(11):1462-8. PubMed ID: 19797255
[TBL] [Abstract][Full Text] [Related]
20. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
